Novavax Analyst Price Targets - Benzinga

Novavax Inc

NVAXNASDAQ

Trade with Public

Trade with Public

$9.78

-0.87-8.17%

Últ. Act.: Nov 6, 4:05 AM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Novavax Analyst Price Targets - Benzinga

Novavax Analyst Price Targets

Wall Street analyst price targets and consensus rating for Novavax (NVAX).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

5Buy

1Hold

3Sell

Consensus RatingBuy# Analysts9Avg. Consensus PT$13Upside to Avg. PT+33.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	Citigroup	Geoff Meacham	PT Raise	Sell	$7→$8
Jun 11, 2026	BTIG	Thomas Shrader	Maintained	Buy	$19
May 6, 2026	TD Cowen	Chris LoBianco	PT Raise	Hold	$8→$9
Feb 27, 2026	HC Wainwright & Co.	Sean Lee	PT Raise	Buy	$11→$16
Jan 20, 2026	BTIG	Thomas Shrader	Maintained	Buy	$19
Nov 18, 2025	JP Morgan	Anupam Rama	PT Cut	Underweight	$7→$6
Nov 10, 2025	B. Riley Securities	Mayank Mamtani	PT Cut	Buy	$18→$16
Nov 4, 2025	TD Cowen	Brendan Smith	PT Cut	Hold	$8→$7
Oct 24, 2025	Cantor Fitzgerald	Pete Stavropoulos	Initiate	Overweight	$18
Oct 23, 2025	HC Wainwright & Co.	Sean Lee	PT Raise	Buy	$10→$11
Aug 28, 2025	HC Wainwright & Co.	Sean Lee	Assumes	Buy	$10
Aug 20, 2025	B of A Securities	Alec Stranahan	Downgrade	Neutral→Underperform	$9→$7
Jul 22, 2025	B of A Securities	Alec Stranahan	PT Cut	Neutral	$10→$9
Jun 17, 2025	Citigroup	Geoff Meacham	Initiate	Sell	$6
May 9, 2025	JP Morgan	Eric Joseph	PT Cut	Underweight	$9→$7
Dec 10, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Nov 13, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Nov 12, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Oct 16, 2024	Jefferies	Roger Song	PT Cut	Buy	$31→$25
Oct 10, 2024	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$23→$26

Analyst Ratings News

PRO
Citigroup Maintains Sell on Novavax, Raises Price Target to $8

Citigroup analyst Geoff Meacham maintains Novavax (NASDAQ:NVAX) with a Sell and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Novavax, Raises Price Target to $9

TD Cowen analyst Chris LoBianco maintains Novavax (NASDAQ:NVAX) with a Hold and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $16

HC Wainwright & Co. analyst Sean Lee maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $11 to $16.

Benzinga Newsdesk

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Avi Kapoor

PRO
B. Riley Securities Reiterates Buy on Novavax, Lowers Price Target to $16

B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $18 to $16.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Novavax, Lowers Price Target to $7

TD Cowen analyst Brendan Smith maintains Novavax (NASDAQ:NVAX) with a Hold and lowers the price target from $8 to $7.

Benzinga Newsdesk